{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:13:56Z","timestamp":1793812436636,"version":"4.6.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T00:00:00Z","timestamp":1655251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T00:00:00Z","timestamp":1655251200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82000881"],"award-info":[{"award-number":["82000881"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82000051"],"award-info":[{"award-number":["82000051"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2018YFC0910202"],"award-info":[{"award-number":["2018YFC0910202"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Beijing cooperative construction project","award":["110651103"],"award-info":[{"award-number":["110651103"]}]},{"DOI":"10.13039\/501100002726","name":"Beijing Normal University","doi-asserted-by":"publisher","award":["11100704"],"award-info":[{"award-number":["11100704"]}],"id":[{"id":"10.13039\/501100002726","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory airway disease caused by inhalation of cigarette smoke (CS) and other harmful gases and particles.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This study aimed to explore potential urinary biomarkers for CS-induced COPD based on LC\u2013MS\/MS analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 340 urinary proteins were identified, of which 79 were significantly changed (30, 31, and 37 at week 2, 4 and 8, respectively). GO annotation of the differential urinary proteins revealed that acute-phase response, response to organic cyclic compounds, complement activation classical pathway, and response to lead ion were significantly enriched at week 2 and 4. Another four processes were only enriched at week 8, namely response to oxidative stress, positive regulation of cell proliferation, thyroid hormone generation, and positive regulation of apoptotic process.\u00a0The PPI network indicated that these differential proteins were biologically connected in CS-exposed rats. Of the 79 differential proteins in CS-exposed rats, 56 had human orthologs. Seven proteins that had changed at week 2 and 4 when there were no changes of pulmonary function and pathological morphology were verified as potential biomarkers for early screening of CS-induced COPD by proteomic analysis. Another six proteins that changed at week 8 when obvious airflow obstruction was detected were verified as potential biomarkers for prognostic assessment of CS-induced COPD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>These results reveal that the urinary proteome could sensitively reflect pathological changes in CS-exposed rats, and provide valuable clues for exploring COPD biomarkers.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12931-022-02070-1","type":"journal-article","created":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T15:02:48Z","timestamp":1655305368000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Proteome analysis of urinary biomarkers in a cigarette smoke-induced COPD rat model"],"prefix":"10.1186","volume":"23","author":[{"given":"Weiwei","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youhe","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,15]]},"reference":[{"key":"2070_CR1","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","volume":"380","author":"R Lozano","year":"2012","unstructured":"Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet. 2012;380:2095\u2013128.","journal-title":"The Lancet"},{"key":"2070_CR2","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.5588\/ijtld.19.0397","volume":"23","author":"DMG Halpin","year":"2019","unstructured":"Halpin DMG, Celli BR, Criner GJ, Frith P, Lopez Varela MV, Salvi S, Vogelmeier CF, Chen R, Mortimer K, Montes de Oca M, et al. The GOLD Summit on chronic obstructive pulmonary disease in low- and middle-income countries. Int J Tuberc Lung Dis. 2019;23:1131\u201341.","journal-title":"Int J Tuberc Lung Dis"},{"key":"2070_CR3","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/resp.14007","volume":"26","author":"P Lange","year":"2021","unstructured":"Lange P, Ahmed E, Lahmar ZM, Martinez FJ, Bourdin A. Natural history and mechanisms of COPD. Respirology. 2021;26:298\u2013321.","journal-title":"Respirology"},{"key":"2070_CR4","doi-asserted-by":"publisher","first-page":"L715","DOI":"10.1152\/ajplung.00361.2009","volume":"298","author":"LM Crosby","year":"2010","unstructured":"Crosby LM, Waters CM. Epithelial repair mechanisms in the lung. Am J Physiol Lung Cell Mol Physiol. 2010;298:L715-731.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2070_CR5","doi-asserted-by":"publisher","first-page":"618","DOI":"10.3390\/diagnostics11040618","volume":"11","author":"N Hashimoto","year":"2021","unstructured":"Hashimoto N, Wakahara K, Sakamoto K. The importance of appropriate diagnosis in the practical management of chronic obstructive pulmonary disease. Diagnostics (Basel). 2021;11:618.","journal-title":"Diagnostics (Basel)"},{"key":"2070_CR6","doi-asserted-by":"publisher","first-page":"200131","DOI":"10.1183\/16000617.0131-2020","volume":"29","author":"ME Laucho-Contreras","year":"2020","unstructured":"Laucho-Contreras ME, Cohen-Todd M. Early diagnosis of COPD: myth or a true perspective. Eur Respir Rev. 2020;29:200131.","journal-title":"Eur Respir Rev"},{"key":"2070_CR7","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1016\/j.chest.2021.01.004","volume":"159","author":"KA Serban","year":"2021","unstructured":"Serban KA, Pratte KA, Bowler RP. Protein biomarkers for COPD outcomes. Chest. 2021;159:2244\u201353.","journal-title":"Chest"},{"key":"2070_CR8","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1080\/14789450.2018.1539670","volume":"15","author":"JY Moon","year":"2018","unstructured":"Moon JY, Leitao Filho FS, Shahangian K, Takiguchi H, Sin DD. Blood and sputum protein biomarkers for chronic obstructive pulmonary disease (COPD). Expert Rev Proteomics. 2018;15:923\u201335.","journal-title":"Expert Rev Proteomics"},{"key":"2070_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117829","volume":"256","author":"F Li","year":"2020","unstructured":"Li F, Xu D, Wang J, Jing J, Li Z, Jin X. Comparative proteomics analysis of patients with quick development and slow development Chronic Obstructive Pulmonary Disease (COPD). Life Sci. 2020;256: 117829.","journal-title":"Life Sci"},{"key":"2070_CR10","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.ebiom.2018.03.009","volume":"30","author":"C Zhang","year":"2018","unstructured":"Zhang C, Leng W, Sun C, Lu T, Chen Z, Men X, Wang Y, Wang G, Zhen B, Qin J. Urine proteome profiling predicts lung cancer from control cases and other tumors. EBioMedicine. 2018;30:120\u20138.","journal-title":"EBioMedicine"},{"key":"2070_CR11","doi-asserted-by":"publisher","first-page":"1700103","DOI":"10.1002\/prca.201700103","volume":"11","author":"J Wu","year":"2017","unstructured":"Wu J, Li X, Zhao M, Huang H, Sun W, Gao Y. Early detection of urinary proteome biomarkers for effective early treatment of pulmonary fibrosis in a rat model. Proteomics Clin Appl. 2017;11:1700103.","journal-title":"Proteomics Clin Appl"},{"key":"2070_CR12","doi-asserted-by":"publisher","first-page":"21446","DOI":"10.1038\/s41598-021-01007-w","volume":"11","author":"W Qin","year":"2021","unstructured":"Qin W, Zhang X, Chen L, Li Q, Zhang B, Sun L, Han W. Differential urine proteome analysis of a ventilator-induced lung injury rat model by label-free quantitative and parallel reaction monitoring proteomics. Sci Rep. 2021;11:21446.","journal-title":"Sci Rep"},{"key":"2070_CR13","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.2147\/JAA.S330054","volume":"14","author":"W Qin","year":"2021","unstructured":"Qin W, Wang T, Liu G, Sun L, Han W, Gao Y. Dynamic urinary proteome changes in ovalbumin-induced asthma mouse model using data-independent acquisition proteomics. J Asthma Allergy. 2021;14:1355\u201366.","journal-title":"J Asthma Allergy"},{"key":"2070_CR14","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.pupt.2012.06.004","volume":"25","author":"YC Nie","year":"2012","unstructured":"Nie YC, Wu H, Li PB, Luo YL, Zhang CC, Shen JG, Su WW. Characteristic comparison of three rat models induced by cigarette smoke or combined with LPS: to establish a suitable model for study of airway mucus hypersecretion in chronic obstructive pulmonary disease. Pulm Pharmacol Ther. 2012;25:349\u201356.","journal-title":"Pulm Pharmacol Ther"},{"key":"2070_CR15","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nmeth.1322","volume":"6","author":"JR Wisniewski","year":"2009","unstructured":"Wisniewski JR, Zougman A, Nagaraj N, Mann M. Universal sample preparation method for proteome analysis. Nat Methods. 2009;6:359\u201362.","journal-title":"Nat Methods"},{"key":"2070_CR16","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, et al. Gene ontology: tool for the unification of biology. Nat Genet. 2000;25:25\u20139.","journal-title":"Nat Genet"},{"key":"2070_CR17","doi-asserted-by":"publisher","first-page":"D330","DOI":"10.1093\/nar\/gky1055","volume":"47","author":"Consortium TGO","year":"2019","unstructured":"Consortium TGO. The gene ontology resource: 20 years and still GOing strong. Nucleic Acids Res. 2019;47:D330\u20138.","journal-title":"Nucleic Acids Res"},{"key":"2070_CR18","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1183\/09031936.00153207","volume":"32","author":"SF Man","year":"2008","unstructured":"Man SF, Xing L, Connett JE, Anthonisen NR, Wise RA, Tashkin DP, Zhang X, Vessey R, Walker TG, Celli BR, Sin DD. Circulating fibronectin to C-reactive protein ratio and mortality: a biomarker in COPD? Eur Respir J. 2008;32:1451\u20137.","journal-title":"Eur Respir J"},{"key":"2070_CR19","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1378\/chest.101.6.1663","volume":"101","author":"AH Limper","year":"1992","unstructured":"Limper AH, Roman J. Fibronectin. A versatile matrix protein with roles in thoracic development, repair and infection. Chest. 1992;101:1663\u201373.","journal-title":"Chest"},{"key":"2070_CR20","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1182\/blood.V56.2.145.145","volume":"56","author":"MW Mosesson","year":"1980","unstructured":"Mosesson MW, Amrani DL. The structure and biologic activities of plasma fibronectin. Blood. 1980;56:145\u201358.","journal-title":"Blood"},{"key":"2070_CR21","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1309\/JC477FAEL1YKV54W","volume":"126","author":"AR Kranenburg","year":"2006","unstructured":"Kranenburg AR, Willems-Widyastuti A, Moori WJ, Sterk PJ, Alagappan VK, de Boer WI, Sharma HS. Enhanced bronchial expression of extracellular matrix proteins in chronic obstructive pulmonary disease. Am J Clin Pathol. 2006;126:725\u201335.","journal-title":"Am J Clin Pathol"},{"key":"2070_CR22","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.coph.2013.05.014","volume":"13","author":"M Schuliga","year":"2013","unstructured":"Schuliga M, Westall G, Xia Y, Stewart AG. The plasminogen activation system: new targets in lung inflammation and remodeling. Curr Opin Pharmacol. 2013;13:386\u201393.","journal-title":"Curr Opin Pharmacol"},{"key":"2070_CR23","doi-asserted-by":"crossref","unstructured":"Baker SK, Strickland S. A critical role for plasminogen in inflammation. J Exp Med. 2020; 217.","DOI":"10.1084\/jem.20191865"},{"key":"2070_CR24","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1177\/147323001204000316","volume":"40","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Xiao W, Jiang Y, Wang H, Xu X, Ma D, Chen H, Wang X. Levels of components of the urokinase-type plasminogen activator system are related to chronic obstructive pulmonary disease parenchymal destruction and airway remodelling. J Int Med Res. 2012;40:976\u201385.","journal-title":"J Int Med Res"},{"key":"2070_CR25","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/labinvest.2015.33","volume":"95","author":"Q Wang","year":"2015","unstructured":"Wang Q, Wang Y, Zhang Y, Zhang Y, Xiao W. Involvement of urokinase in cigarette smoke extract-induced epithelial-mesenchymal transition in human small airway epithelial cells. Lab Invest. 2015;95:469\u201379.","journal-title":"Lab Invest"},{"key":"2070_CR26","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/crj.12146","volume":"9","author":"NE Viby","year":"2015","unstructured":"Viby NE, Pedersen L, Lund TK, Kissow H, Backer V, Nexo E, Thim L, Poulsen SS. Trefoil factor peptides in serum and sputum from subjects with asthma and COPD. Clin Respir J. 2015;9:322\u20139.","journal-title":"Clin Respir J"},{"key":"2070_CR27","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.peptides.2014.09.026","volume":"63","author":"NE Viby","year":"2015","unstructured":"Viby NE, Nexo E, Kissow H, Andreassen H, Clementsen P, Thim L, Poulsen SS. Trefoil factors (TFFs) are increased in bronchioalveolar lavage fluid from patients with chronic obstructive lung disease (COPD). Peptides. 2015;63:90\u20135.","journal-title":"Peptides"},{"key":"2070_CR28","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1165\/ajrcmb.25.4.f215","volume":"25","author":"SR White","year":"2001","unstructured":"White SR. Trefoil peptides in airway epithelium: an important addition to the plethora of peptides. Am J Respir Cell Mol Biol. 2001;25:401\u20134.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2070_CR29","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.pharmthera.2013.10.008","volume":"141","author":"SG Royce","year":"2014","unstructured":"Royce SG, Moodley Y, Samuel CS. Novel therapeutic strategies for lung disorders associated with airway remodelling and fibrosis. Pharmacol Ther. 2014;141:250\u201360.","journal-title":"Pharmacol Ther"},{"key":"2070_CR30","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1517\/14728222.2016.1113260","volume":"20","author":"SC Su","year":"2016","unstructured":"Su SC, Lin CW, Yang WE, Fan WL, Yang SF. The urokinase-type plasminogen activator (uPA) system as a biomarker and therapeutic target in human malignancies. Expert Opin Ther Targets. 2016;20:551\u201366.","journal-title":"Expert Opin Ther Targets"},{"key":"2070_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2020.152885","volume":"216","author":"C Zhu","year":"2020","unstructured":"Zhu C, Jiang L, Xu J, Ren A, Ju F, Shu Y. The urokinase-type plasminogen activator and inhibitors in resectable lung adenocarcinoma. Pathol Res Pract. 2020;216: 152885.","journal-title":"Pathol Res Pract"},{"key":"2070_CR32","doi-asserted-by":"publisher","first-page":"10573","DOI":"10.3748\/wjg.v21.i37.10573","volume":"21","author":"N Tsuchiya","year":"2015","unstructured":"Tsuchiya N, Sawada Y, Endo I, Saito K, Uemura Y, Nakatsura T. Biomarkers for the early diagnosis of hepatocellular carcinoma. World J Gastroenterol. 2015;21:10573\u201383.","journal-title":"World J Gastroenterol"},{"key":"2070_CR33","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1172\/JCI130197","volume":"130","author":"D Wu","year":"2020","unstructured":"Wu D, Zhang S, Xie Z, Chen E, Rao Q, Liu X, Huang K, Yang J, Xiao L, Ji F, et al. Plasminogen as a prognostic biomarker for HBV-related acute-on-chronic liver failure. J Clin Invest. 2020;130:2069\u201380.","journal-title":"J Clin Invest"},{"key":"2070_CR34","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/prca.201300072","volume":"8","author":"F Cynthia Martin","year":"2014","unstructured":"Cynthia Martin F, Hiller M, Spitali P, Oonk S, Dalebout H, Palmblad M, Chaouch A, Guglieri M, Straub V, Lochmuller H, et al. Fibronectin is a serum biomarker for Duchenne muscular dystrophy. Proteomics Clin Appl. 2014;8:269\u201378.","journal-title":"Proteomics Clin Appl"},{"key":"2070_CR35","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.clinbiochem.2009.10.012","volume":"43","author":"C Kuk","year":"2010","unstructured":"Kuk C, Gunawardana CG, Soosaipillai A, Kobayashi H, Li L, Zheng Y, Diamandis EP. Nidogen-2: a new serum biomarker for ovarian cancer. Clin Biochem. 2010;43:355\u201361.","journal-title":"Clin Biochem"},{"key":"2070_CR36","doi-asserted-by":"publisher","first-page":"3062","DOI":"10.7150\/jca.19619","volume":"8","author":"L Zeng","year":"2017","unstructured":"Zeng L, Zhong J, He G, Li F, Li J, Zhou W, Liu W, Zhang Y, Huang S, Liu Z, Deng X. Identification of nucleobindin-2 as a potential biomarker for breast cancer metastasis using iTRAQ-based quantitative proteomic analysis. J Cancer. 2017;8:3062\u20139.","journal-title":"J Cancer"},{"key":"2070_CR37","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1186\/s12885-018-4952-y","volume":"18","author":"CH Lee","year":"2018","unstructured":"Lee CH, Im EJ, Moon PG, Baek MC. Discovery of a diagnostic biomarker for colon cancer through proteomic profiling of small extracellular vesicles. BMC Cancer. 2018;18:1058.","journal-title":"BMC Cancer"},{"key":"2070_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0204204","volume":"13","author":"JH Lim","year":"2018","unstructured":"Lim JH, Lee CH, Kim KY, Jung HY, Choi JY, Cho JH, Park SH, Kim YL, Baek MC, Park JB, et al. Novel urinary exosomal biomarkers of acute T cell-mediated rejection in kidney transplant recipients: a cross-sectional study. PLoS ONE. 2018;13: e0204204.","journal-title":"PLoS ONE"},{"key":"2070_CR39","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.ebiom.2019.03.056","volume":"42","author":"R Jahan","year":"2019","unstructured":"Jahan R, Ganguly K, Smith LM, Atri P, Carmicheal J, Sheinin Y, Rachagani S, Natarajan G, Brand RE, Macha MA, et al. Trefoil factor(s) and CA19.9: a promising panel for early detection of pancreatic cancer. EBioMedicine. 2019;42:375\u201385.","journal-title":"EBioMedicine"},{"key":"2070_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2020.188362","volume":"1873","author":"R Jahan","year":"2020","unstructured":"Jahan R, Shah A, Kisling SG, Macha MA, Thayer S, Batra SK, Kaur S. Odyssey of trefoil factors in cancer: diagnostic and therapeutic implications. Biochim Biophys Acta Rev Cancer. 2020;1873: 188362.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"2070_CR41","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/leu.2017.287","volume":"32","author":"AG Solimando","year":"2018","unstructured":"Solimando AG, Brandl A, Mattenheimer K, Graf C, Ritz M, Ruckdeschel A, Stuhmer T, Mokhtari Z, Rudelius M, Dotterweich J, et al. JAM-A as a prognostic factor and new therapeutic target in multiple myeloma. Leukemia. 2018;32:736\u201343.","journal-title":"Leukemia"},{"key":"2070_CR42","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s11060-017-2555-0","volume":"135","author":"AM Rosager","year":"2017","unstructured":"Rosager AM, Sorensen MD, Dahlrot RH, Boldt HB, Hansen S, Lathia JD, Kristensen BW. Expression and prognostic value of JAM-A in gliomas. J Neurooncol. 2017;135:107\u201317.","journal-title":"J Neurooncol"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-022-02070-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-022-02070-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-022-02070-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T16:06:21Z","timestamp":1655309181000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-022-02070-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,15]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2070"],"URL":"https:\/\/doi.org\/10.1186\/s12931-022-02070-1","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,15]]},"assertion":[{"value":"31 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Male Wistar rats (180\u2013200\u00a0g) were purchased from Charles River China (Beijing, China). The animal experiments were reviewed and approved by Qingdao Municipal Hospital Medical Ethics Committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"156"}}